Drug Drug Interaction not checked

Vicore Pharma AB

FollowEvery change as it happens, and a Monday email
Stage
No active trials
 
Next date
None yet
 
Trials
0 active
1 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“The intervention phase consists of 3 periods: in period 1, the pharmacokinetics (PK) of all substrates will be evaluated in the absence of C21, in period 2, a potential inhibitory effect of C21 on the substrates be evaluated, and in period 3, the net effect of potential C21-mediated induction and inhibition on the substrates will be evaluated”In the company’s words, NCT05830799 on ClinicalTrials.gov
Tested for
Drug Interaction
Main trialPhase 1
“This is a single-centre, open-label, fixed-sequence trial to evaluate the impact of C21 on the exposure of CYP1A2, CYP2C9, CYP3A4 and P-gp substrates in healthy volunteers.”In the company’s words, NCT05830799 on ClinicalTrials.gov
Other names
Caffeine · Koffein Meda · Tolbutamide · Tolbutamide CF · Midazolam · Midazolam APL · Nintedanib · Ofev

Other drugs for Drug Interaction

All 158 drugs for Drug Interaction

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials1

TrialPhaseCompletesWhat it tests
Phase 1Completed 11 May 2023 A Trial to Evaluate the Impact of C21 on the Exposure of 4 Substrates in Healthy Volunteers
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow Drug Drug Interaction

Following is part of Solo: you see every change to Drug Drug Interaction the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in